|
Market Closed -
Other stock markets
|
After hours 01:57:12 am | |||
| 130.34 USD | +0.05% |
|
134.48 | +3.18% |
| 06:22pm | What Bundibugyo Ebola vaccines and treatments are under development | RE |
| 21/07 | Gilead Sciences Shares Fall After Downgrade From Leerink Partners | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.05% | -1.03% | +4.38% | -1.93% | +6.19% | +18.31% | +67.83% | +89.86% | +50.60% | 16TCr | |
| -1.05% | +0.55% | +5.53% | +26.21% | +8.22% | +49.79% | +153.20% | +387.66% | +1,325.43% | 1,04800Cr | |
| +2.00% | +3.49% | +10.52% | +13.06% | +23.52% | +52.22% | +49.42% | +50.39% | +104.45% | 60TCr | |
| -1.09% | +3.76% | +10.13% | +26.33% | +10.86% | +35.37% | +76.91% | +115.50% | +296.96% | 45TCr | |
| -0.42% | +1.65% | +3.94% | +4.79% | +1.28% | +30.05% | +21.05% | -6.62% | +32.96% | 33TCr | |
| -0.16% | +2.39% | +5.95% | +7.96% | +14.36% | +36.91% | +37.33% | +51.45% | +52.95% | 28TCr | |
| +1.68% | +2.73% | -4.02% | -12.76% | -7.89% | +24.14% | +17.94% | +50.16% | +180.80% | 26TCr | |
| -1.40% | -0.06% | +9.06% | +29.30% | -1.77% | -22.24% | -42.39% | +14.11% | +71.50% | 22TCr | |
| -0.05% | +2.16% | +6.19% | +5.82% | +11.84% | +19.75% | +55.49% | +49.57% | +120.95% | 20TCr | |
| -0.48% | 0.00% | -1.04% | -7.39% | -0.32% | -1.27% | -33.83% | -40.15% | -32.44% | 14TCr | |
| -0.28% | +3.47% | +11.08% | +3.33% | +12.64% | +26.53% | -6.13% | -10.59% | -19.71% | 12TCr | |
| -1.96% | -0.95% | +1.24% | +7.97% | +4.24% | +0.52% | +32.35% | +141.08% | +403.32% | 12TCr | |
| +0.12% | +1.77% | +3.64% | -5.16% | -7.11% | -6.63% | -22.08% | -11.71% | +0.81% | 11TCr | |
| +0.92% | -0.52% | -0.78% | -8.24% | +4.71% | +42.15% | +37.62% | +8.11% | -6.69% | 10TCr | |
| -1.23% | +0.90% | -3.23% | -15.97% | -11.37% | +4.31% | +82.33% | +77.03% | +489.19% | 7.47TCr | |
| +0.84% | +1.04% | +14.39% | -0.65% | -7.02% | -4.50% | +20.60% | -12.05% | +250.09% | 5.35TCr | |
| -0.05% | +4.22% | +12.53% | +1.17% | +14.83% | +27.90% | +26.56% | +49.65% | +23.05% | 5.44TCr | |
| -1.36% | -4.38% | +24.13% | +17.51% | +26.91% | +70.46% | -9.57% | -8.01% | -48.97% | 5.34TCr | |
| -0.73% | +1.55% | +9.55% | +3.86% | -2.37% | +3.27% | +8.30% | - | - | 4.34TCr | |
| -1.61% | -4.35% | -6.78% | -14.04% | -32.86% | -17.92% | +38.83% | +46.85% | +307.68% | 3.62TCr | |
| Average | -0.17% | +1.40% | +5.82% | +4.06% | +3.45% | +19.46% | +30.59% | +54.86% | +189.63% | 22.31TCr | |
| Weighted average by Cap. | -0.12% | +1.70% | +6.03% | +11.97% | +7.76% | +31.33% | +60.46% | +126.89% | +409.24% |
- Stock Market
- Stocks
- GILD Stock
- Sector Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
